SGLT‐2 inhibitors vs sulphonylureas
Adverse events other than hypoglycaemia
It is very uncertain whether SGLT‐2 inhibitors changes adverse events other than hypoglycaemia compared with sulphonylureas (very low certainty).
1 finding from 1 review
- Interventions for people with type 2 diabetes mellitus fasting during Ramadan 2023 · Cochrane Headline outcomes onlyRR 1 [0.6, 1.67]1 study · 110 participantsVery low